| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |